Clincosm LogoSign in Get a demo

lymphoma

Showing NaN - NaN of 111
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, Adult Trial in United States (LNS8801 -Small molecule, orally bioavailable, selective agonist of GPER,

Recruiting
  • Solid Tumor, Adult
  • Lymphoma
  • LNS8801 -Small molecule, orally bioavailable, selective agonist of GPER
  • Pembrolizumab - anti-PD-1 antibody
  • Los Angeles, California
  • +7 more
Oct 11, 2021

Lymphoma Trial in Germany, Spain, United States (cemiplimab, REGN1979)

Active, not recruiting
  • Lymphoma
  • Santa Monica, California
  • +21 more
Sep 20, 2021

Solid Tumors, Lymphoma Trial in Boston, Philadelphia (PM00104)

Terminated
Has Results
  • Solid Tumors
  • Lymphoma
  • Boston, Massachusetts
  • +1 more
Jul 7, 2021

Lymphoma Trial in United States (biological, drug, radiation, procedure)

Completed
Has Results
  • Lymphoma
  • Bleomycin Sulfate
  • +11 more
  • Tucson, Arizona
  • +94 more
Jun 10, 2021

Lymphoma Trial in Philadelphia (Fludeoxyglucose F18, Computed Tomography, Positron emission tomography)

Completed
Has Results
  • Lymphoma
  • Fludeoxyglucose F18
  • +2 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Apr 27, 2021

Lymphoma Trial in Philadelphia (Pembrolizumab)

Withdrawn
  • Lymphoma
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
May 5, 2021

Lymphoma, Relapsed Lymphoma, Refractory Lymphoma Trial in United States (fimepinostat, Rituximab, venetoclax)

Completed
  • Lymphoma
  • +10 more
  • Los Angeles, California
  • +10 more
May 5, 2021

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell Trial in United States (OT-82 Dose Escalation, OT-82 Dose Expansion)

Recruiting
  • Lymphoma
  • +6 more
  • OT-82 Dose Escalation
  • OT-82 Dose Expansion
  • Birmingham, Alabama
  • +7 more
Oct 22, 2020

Breast Carcinoma, Cancer Survivor, Depression Trial in United States (procedure, other, behavioral)

Completed
  • Breast Carcinoma
  • +12 more
  • Management of Therapy Complications
  • +3 more
  • Los Angeles, California
  • +5 more
Oct 8, 2020

Lymphoma Trial in United States (biological, drug, genetic)

Completed
  • Lymphoma
  • rituximab
  • +7 more
  • La Jolla, California
  • +16 more
Aug 7, 2020

Blood and Tissue Samples From Aggressive Non-Hodgkin B-Cell

Completed
  • Lymphoma
  • Nonneoplastic Condition
  • polymerase chain reaction
  • laboratory biomarker analysis
  • La Jolla, California
  • +15 more
Aug 6, 2020

Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Detroit, Cleveland, Philadelphia (educational

Completed
  • Brain and Central Nervous System Tumors
  • +8 more
  • educational intervention
  • Detroit, Michigan
  • +3 more
Jul 23, 2020

Lymphoma Trial in United States (enzastaurin, rituximab, cyclophosphamide)

Completed
Has Results
  • Lymphoma
  • Huntsville, Alabama
  • +24 more
Jul 20, 2020

Leukemia, Lymphoma Trial in Canada, United States (biological, drug, procedure, radiation)

Terminated
  • Leukemia
  • Lymphoma
  • therapeutic allogeneic lymphocytes
  • +8 more
  • Denver, Colorado
  • +22 more
Apr 8, 2020

Hematological Malignancies, Leukemia, Lymphoma Trial in Philadelphia (Matched Sibling Allogeneic Transplantation)

Completed
Has Results
  • Hematological Malignancies
  • +4 more
  • Matched Sibling Allogeneic Transplantation
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Sep 27, 2019

Lymphoma Trial in Worldwide (asparaginase, cyclophosphamide, cytarabine)

Completed
Has Results
  • Lymphoma
  • Birmingham, Alabama
  • +175 more
Jul 24, 2019

Cancer, Leukemia, Lymphoma Trial in Philadelphia (Sirolimus and Methotrexate)

Completed
Has Results
  • Cancer
  • +2 more
  • Sirolimus and Methotrexate
  • Philadelphia, Pennsylvania
    The Children's Hospital of Philadelphia
Jul 12, 2019

Leukemia, Lymphoma, HIV Trial in United States (Fludarabine and Busulfan, Fludarabine and Melphalan, Busulfan and Fludarabine)

Completed
Has Results
  • Leukemia
  • +2 more
  • Fludarabine and Busulfan
  • +3 more
  • Phoenix, Arizona
  • +10 more
Dec 6, 2018

Leukemia, Lymphoma Trial in Baltimore, Philadelphia (Filgrastim, Rituximab, Cyclophosphamide)

Completed
Has Results
  • Leukemia
  • Lymphoma
  • Filgrastim
  • +8 more
  • Baltimore, Maryland
  • +1 more
Sep 13, 2018

Patients Previously Treated for Childhood Hodgkin's Lymphoma

Completed
  • Long-term Effects Secondary to Cancer Therapy in Children
  • Lymphoma
  • medical chart review
  • +2 more
  • Palo Alto, California
  • +14 more
Jul 13, 2018

Lymphoma Trial in United States (filgrastim, pegfilgrastim, rituximab)

Completed
Has Results
  • Lymphoma
  • filgrastim
  • +12 more
  • La Jolla, California
  • +12 more
May 3, 2018

Lymphoma Trial in United States (biological, drug, other)

Completed
Has Results
  • Lymphoma
  • filgrastim
  • +9 more
  • La Jolla, California
  • +13 more
May 3, 2018

Brain and CNS Tumors, Lymphoma Trial in United States (rituximab, methotrexate, temozolomide 100 mg/m^2)

Completed
Has Results
  • Brain and Central Nervous System Tumors
  • Lymphoma
  • Jacksonville Beach, Florida
  • +25 more
Feb 1, 2018

Lymphoma Trial in Canada, South Africa, United States (Doxorubicin, Bleomycin, Vinblastine)

Completed
Has Results
  • Lymphoma
  • Mobile, Alabama
  • +538 more
Oct 18, 2017

Lymphoma Trial in Worldwide (Inotuzumab Ozogamicin (CMC-544))

Completed
Has Results
  • Lymphoma
  • Inotuzumab Ozogamicin (CMC-544)
  • Birmingham, Alabama
  • +41 more
Oct 27, 2017